The earliest atherosclerotic lesions characteristically develop with focal patterns (ie, preferentially at branches and curves of the arterial tree) where the local blood flow is disturbed. 4 The endothelium lining these atherosuscepetible regions have (1) increased permeability to plasma macromolecules, (2) increased turnover (proliferation and apoptosis), and (3) increased adhesiveness for monocytes that attach and migrate into the arterial wall, with subsequent alterations in EC morphology and Abstract-Atherosclerosis develops preferentially at branches and curvatures of the arterial tree, where blood flow pattern is disturbed rather than being laminar, and wall shear stress has an irregular distribution without defined directions. The endothelium in the atherosusceptible regions, in comparison to that in atheroresistant regions, shows activation of proproliferative and proinflammatory gene expressions, reduced production of nitric oxide (NO), increased leukocyte adhesion, and permeability, as well as other atheroprone phenotypes. Differences in gene expressions and cell phenotypes have been detected in endothelia residing in native atherosusceptible and atheroresistant regions of the arteries, or in arteries from animal models with artificial creation of disturbed flow. Similar results have also been shown in in vitro systems that apply controlled shear stresses with or without clear directions to cultured endothelial cells in fluid-dynamically designed flow-loading devices. The available evidence indicates that the coordination of multiple signaling networks, rather than individual separate pathways, links the mechanical signals to specific genetic circuitries in orchestrating the mechanoresponsive networks to evoke comprehensive genetic and functional responses. (Arterioscler Thromb Vasc Biol. 2014;34:2191-2198.)
T he interactions of blood flow with complex vessel geometry generate hemodynamic characteristics, including the heterogeneous spatial and temporal mechanical forces acting on the vessel wall. Vascular endothelial cells (ECs) covering the inner surface of blood vessels are constantly exposed to shear stress because of the frictional force created by the blood flow. ECs respond to the changes of local shear stress to modulate intracellular signaling, which leads to alterations of gene expression, cell morphology, and structural remodeling. 1, 2 Please see http://atvb.ahajournals.org/site/misc/ ATVB_in_Focus.xhtml for all articles published in this series.
The correlation of atheroma location and site-specific endothelial dysfunctional phenotype with the nonlaminar characteristics of blood flow and shear stress at curved regions, branch points, and bifurcations indicates that such disturbed flow patterns are atheroprone. At these atheroprone regions, the flow departs from pulsatile, unidirectional shear stress to create flow-separation zones that include flow reversal, oscillating shear stress, and occasional turbulence. 3 In contrast, the shear stress in the straight atheroresistant part of the arteries is pulsatile and has well-defined directions. The shear stresses resulting from different flow patterns initiate differential steps of signaling events in the endothelium, including mechanosensing, intracellular transmission of stress, conversion of mechanical force to biochemical signals, and feedback mechanisms. 3 As a result, the endothelium develops different adaptive phenotypes to differentially react with other coexistent risk factors, such as high cholesterol, hypertension, obesity, diabetes mellitus, and smoking, to contribute to the site-specific susceptibility for the initiation and progression of atherosclerosis. The aim of this review is to provide a brief summary of the current knowledge with a focus on the shear stress-initiated signaling and its regulation of endothelial function and dysfunction, as well as the communication between ECs and other vascular cells. The pathological implications in atherosclerosis and future perspectives are also discussed. The effects of fluid shear stress on endothelial gene expression and the functional consequences have been previously reviewed in depth. 2, 4 structure. 4 Changes in expression or activation of signaling and functional molecules have been observed in the endothelium of atherosclerotic plaques or atherosusceptible regions (eg, inner curvatures of aortic arch or carotid bifurcations) when compared with nonlesion regions or the straight segments (eg, the descending thoracic aorta). Examples of molecules involved include the vascular factors related to homeostasis: endothelial nitric oxide synthase (eNOS), 5 NF-E2-related factor 2, 6 Kruppel-like factor 2 (KLF2), 7 pregnane X receptor, 8 AMP-activated protein kinases, 9 microRNA (miR)-10a, 10 angiopoietin-2, 11 as well as other factors related to stress responses: platelet-derived growth factors and their receptors, 12 early growth response protein 1, 13 nuclear factor-κB, [14] [15] [16] toll-like receptors, 17 p21-activated kinases, 18 SHC (Src homology 2 domain containing) transforming protein 1, 19 c-Jun N-terminal kinase, 20 x-box binding protein 1, 21 histone deacetylase 3, 22 bone morphogenetic protein-2/-4 (BMP2/4), 23, 24 SMAD family member 1 and 5 (Smad1/5), 25 monocyte chemoattractant protein-1 (MCP-1), 26 intercellular adhesion molecule 1 (ICAM-1), [27] [28] [29] vascular cell adhesion protein 1 (VCAM-1), [28] [29] [30] and endothelial leukocyte adhesion molecule 1 (E-selectin). 27
Endothelial Phenotypes in Experimental Models of Disturbed Flow In Vivo
Several animal models have been created to study the effects of disturbed flow with oscillatory and low shear stress on endothelial phenotypic responses. The strategies commonly used to create disturbed flow are the following:
The introduction of a local stenosis by constricting a segment of a large vessel, such as the carotid artery or abdominal aorta of mice, rats, or rabbits. [31] [32] [33] Although ECs are well aligned and elongated in the direction of flow at the stenosis throat, where the flow is laminar with a relatively high shear stress, the cells immediately downstream to the stenosis throat are rounded and their proliferation is significantly increased 25 in this poststenotic region with flow separation and low-velocity recirculation. 31, 32 The vascular endothelial-cadherin in endothelial adherens junctions 34 and the endothelial-protective KLF2 7 are highly expressed in ECs in regions with laminar flow but not in the downstream regions with disturbed flow. In addition, BMP receptor-specific Smad1/5 are found to be highly phosphorylated in ECs at poststenotic sites to cause cell cycle progression and cell proliferation. 25 The partial ligation of a carotid artery of rats or mice. In this model, the 3 branches (external carotid, internal carotid, and occipital) of 1 carotid artery are ligated and the superior thyroid artery is left intact, resulting in low and oscillating shear stress in the common carotid artery of the operated side. 35 The partial ligation downregulates KLF2 and eNOS while upregulating ICAM-1, VCAM-1, and BMP4, and it impairs endothelium-dependent vasorelaxation and induces atherosclerosis in ApoE −/− mice fed a high-fat diet. 35 The creation of an arteriovenous fistula (AVF). This is often created between the carotid artery and the jugular vein or between the femoral artery and the femoral vein of rats or larger animals, such as rabbit or swine, with juxta-anastomotic AVF. The AVF causes low and oscillating wall shear stress in zones where flow stagnation occurs on the outer wall of the artery and on the inner wall of the juxta-anastomotic site. 36, 37 In the venous segment of the rat AVF model, MCP-1 mRNA and protein increase in both the ECs and smooth muscle cells (SMCs), accompanied by increased activities of the transcription factors nuclear factor-κB and activator protein 1. 38 In the swine AVF model, significant luminal stenosis and intima-media thickening are present as early as 28 and 42 days after surgery, respectively, in the juxta-anastomotic regions of the femoral artery and vein. 37 All the in vivo results indicate that flow patterns play significant roles in vascular homeostasis. The mechanotransduction mechanisms involved have been analyzed by using in vitro flow systems, where the mechanical stimuli applied can be controlled and the molecular and functional responses can be studied in detail.
Shear Stress-Induced Signal Transduction, Gene Expression, and Phenotypic Changes in ECs Mechanosensing and Signaling in ECs
In vitro investigations have shown that application of shear stress to ECs can activate multiple mechanosensors located at the cell membrane (the biomolecules that are the initial responders to the changes in mechanical environment to trigger mechanotransduction). These include integrins, 39, 40 tyrosine kinase receptors (particularly vascular endothelial growth factor receptor-2), 41 G proteins and G-protein-coupled receptors, 42 ion channels, 43 and intercellular junction proteins. 44 Other possible mechanosensors are local membrane structures, such as caveolae, gap junctions, membrane lipids, and glycocalyx. 45 The mechanosensing, transmitted via adaptor molecules, triggers a cascade of signaling pathways and modulates the expression of functional genes (eg, genes concerned with proliferation or growth arrest, inflammation or anti-inflammation, and many others). For example, integrins (α v β 3 , α 2 β 1 , α 5 β 1 , and α 6 β 1 ), which mediate the effects of shear stress on cytoskeletal proteins (eg, actin filaments), typically trigger both outside-in and inside-out signals to transmit and modulate the tensions among focal adhesion sites, membrane receptors, and the extracellular matrix. 1, 39, 40 Integrin activation results in phosphorylation of focal adhesion kinase, Paxillin, and p130CAS (Crk-associated substrate) and leads to the activation of mitogen-activated protein kinases via Ras GTPase. 46 The activation of vascular endothelial growth factor 
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receptor-2 by shear stress results in its association with casitas B-lineage lymphoma (Cbl), vascular endothelial-cadherin, β-cadherin-associated protein (catenin), and phosphatidylinositol-3-kinase to phosphorylate the downstream Akt (protein kinase B). 41 Shear stress regulates EC alignment and remodeling through the activation of Rho family GTPases (Cdc42, Rho, and Rac) that enhance the formation of stress fibers and focal adhesions and regulates cytoskeletal reorganization. 42, 47 In addition, shear stress preferentially increases membrane fluidity at the upstream side of the ECs; this may induce the polarization of the cell and facilitate the lateral mobility of membrane proteins and enhance their interactions. 45, 48 Increasing evidence suggests that those mechanosensing and signaling mechanisms in ECs are not mutually exclusive but are most likely interconnected. Recently, transmembrane proteins Piezo1 and Piezo2 have been identified as essential components of mechanically activated ion channels 49, 50 in many cell types and may also serve as novel mechanotransduction molecules in ECs. Yes-associated protein and transcriptional coactivator with PDZ-binding motif have also been identified recently as nuclear relays of mechanical signals exerted by extracellular matrix rigidity and cell shape. 51 Therefore, Yes-associated protein/PDZ-binding motif are suggested to serve as novel sensors and mediators of mechanical cues. 51 Investigations on the involvement and functions of Piezo and Yes-associated protein/PDZ-binding motif in shear stressinduced signaling in ECs may be an attractive direction for mechanobiochemical transduction research.
Shear Stress-Induced Gene Expression and Functional Consequences in ECs
eNOS is the essential molecule for the synthesis and release of the potent vasodilator, antioxidant, and anti-inflammatory mediator: nitric oxide. Impaired expression of eNOS is a crucial element for fluid shear stress regulation of site-specific endothelial functional phenotype. In both cultured ECs and intact vessels, atheroprotective laminar shear stress (LSS; mean stress, ≥12 dyn/cm 2 without oscillation) upregulates the protein expression level and activity of eNOS. 52, 53 The mechanism responsible for shear stress regulation of eNOS remains unclear despite some suggestions of regulatory pathways based on in vitro investigation. The well-characterized residues for flow-regulated eNOS phosphorylation are active sites Ser 1177, Ser 633, Ser 635, and inhibitory sites Tyr 657. [54] [55] [56] [57] LSS stimulates Akt phosphorylation, which in turn phosphorylates eNOS at Ser 1177, leading to eNOS activation and NO production. 54 LSS also increases the expression of prolinerich tyrosine kinase 2 and its association with eNOS, which phosphorylates eNOS at the repressive Tyr 657 and hence decreases eNOS activity. 56 The proline-rich tyrosine kinase 2-dependent inhibition of NO production may serve to balance the eNOS activity and to limit the detrimental overproduction of NO (ie, the generation of cytotoxic peroxynitrite).
Another key molecule for vascular endothelial homeostasis is the KLF family zinc finger-containing transcription factor. KLF2 is abundantly expressed in ECs and positively regulates eNOS expression. Atheroprotective LSS or pulsatile shear stress (PSS; mean stress, ≥12 dyn/cm 2 with oscillation), but not atheroprone oscillatory shear stress (OSS; mean stress, 0-0.5 dyn/cm 2 with oscillation), causes a sustained increase of the mRNA level of KLF2 via the mediation of the signaling cascade comprising extracellular-signal-regulated kinase-5, myocyte enhancer factor-2, AMP-activated protein kinases, and miR-92a to result in increased eNOS expression. 58, 59 Other mechanisms contributing to shear stress-mediated eNOS expression and activation include protein kinase A, 55 NF-E2-related factor 2, 60 SIRT1, 57 and other histone deacetylases (eg, histone deacetylase 5). 61 The interactions among these signaling pathways remain to be elucidated. Increased expression of biomarkers, such as MCP-1, ICAM-1, VCAM-1, and E-selectin, are a hallmark of the endothelial inflammatory phenotype in atherosusceptible regions. The initial application of LSS to static ECs causes a brief Ras GTPase and mitogen-activated protein kinase activation, which leads to the transient MCP-1 gene expression; prolonged LSS, however, decreases Ras activity and MCP-1 expression. 1 Such repression of MCP-1 by sustained LSS may be a result of eNOS expression and NO production that inhibit protein kinase C-ε and extracellular-signal-regulated kinase 1/2. 62 Furthermore, prolonged PSS induces the AMP-activated protein kinases/poly [ADP ribose] polymerase 1/B-cell lymphoma-6 pathway to inhibit expressions of VCAM-1, MCP-1, and MCP-3. 63 The Tie family of receptor tyrosine kinases has been shown to contribute to the proinflammatory endothelial phenotype, as indicated by the findings that depletion of Tie1 augments the LSSinduced simulation of eNOS and inhibitions of κ B activity and ICAM-1 expression. 64 In contrast, OSS induces MCP-1 and VCAM-1 activities; these are mediated by the miR-21/peroxisome proliferator-activated receptor α/activator protein 1 cascade. 65 OSS induces a sustained miR-21 expression to inhibit peroxisome proliferator-activated receptor α translation, leading to the activation of activator protein 1 and its association with the promoter regions of MCP-1 and VCAM-1 to increase their expressions. 65 Flow-sensitive miR-10a has been demonstrated to provoke endothelial inflammation via nuclear factor-κB-mediated activation of MCP-1, VCAM-1, E-selectin, and interleukins, IL-6 and IL-8. 10 BMP-4 has been shown to exert proinflammatory effects on endothelium. OSS induces endothelial BMP-4 expression, which in turn activates ICAM-1 expression and monocyte adhesion through the production of reactive oxygen species. 66 Histone deacetylase-3/5/7 have been found to mediate the inductive effect of OSS on VCAM-1 expression. 67 A recent investigation shows that the application of OSS to ECs activates sterol regulatory element binding protein 2 to induce NLRP3 (NLR family, pyrin domain containing 3) inflammation, and hence the increased innate immunity to cause topographical distribution of atherosclerotic lesions. 68 Evidence from in vivo animal models, with the introduction of disturbed flow, suggests that increased EC proliferation is an early event of site-specific atherogenesis. In vitro studies verify that prolonged LSS or PSS reduces the number of ECs with bromodeoxyuridine incorporation and prevents ECs from entering S phase, with the majority of cells arrested in the G 0 or G 1 phase. 69, 70 In contrast, cells exposed to OSS, or at the disturbed flow reattachment area, have accelerated turnover rate with enhanced G 0 /G 1 -S transition. 25, 26 Among October 2014 the important mediators involved in flow-regulated cell cycle progression are Smad1/5. Application of OSS to ECs causes the sustained phosphorylation of Smad1/5 through integrin/ BMP receptor association and focal adhesion kinase/extracellular-signal-regulated kinase cascade, resulting in activation of the mammalian target of rapamycin/p70S6 kinase, and leading to the upregulation of cyclin A, downregulation of p21 and p27, and consequential cell cycle progression. 25, 71 LSS stabilizes the tumor suppressor protein p53 and increases its phosphorylation by c-Jun N-terminal kinase, thus leading to the inhibition of EC growth. 69 LSS also increases the expression of the growth arrest proteins GADD45 (growth arrest and DNA damage inducible protein 45) and p21, and decreases the phosphorylation of the retinoblastoma, thus leading to cell cycle arrest. 69 MicroRNAs have been identified recently as important players in the regulation of endothelial proliferation under shear stress. We have shown with our collaborators that miR-19a 72 and miR-23b 70 mediate the LSS/PSS-induced cell cycle arrest via a decrease in E2F1 and hypophosphorylation of retinoblastoma or directly targeting cyclin D1. All these findings demonstrate that shear flows with and without a clear direction differentially activate multiple signaling events to modulate EC growth ( Figure 1) ; these findings have helped to elucidate the molecular mechanisms underlying the focal nature of vascular diseases.
Shear stresses with different flow patterns induce differential gene expression and functional consequences via complex mechanisms, which also include redox regulation, 73 endoplasmic reticulum-stress and protein unfolding, 74 and lipid metabolism. 75 Systems biology approaches such as highthroughput transcriptomics, proteomics, and miR-omics have been used to investigate the shear stress-induced gene expressions and the consequential phenotypes in ECs in vitro or in vivo. 70, [76] [77] [78] [79] In an in vitro flow model, miR profiling in ECs showed that 21 miRs were differentially expressed (8 upregulated and 13 downregulated) in response to 24 hours of PSS when compared with static condition. 70 In an in vivo disturbed flow model, 62 and 523 genes were found to change significantly in the endothelium of mouse carotid arteries by 12 and 48 hours after partial ligation, respectively. 76 This study led to the discovery of novel mechanosensitive genes, including LIM domain only 4, Kallikrein-related peptidase 10, and desert hedgehog. 76 In native atherosusceptible and atheroresistant regions in porcine aorta, cDNA microarray was used to study gene expressions in the endothelium, and ≈2000 putatively differentially expressed genes were identified. Analyses of these differentially expressed gene indicated that atheroprone flow primes ECs toward inflammatory responses pending on other risk factors. 80 However, proteomics and other comprehensive system-wide analyses, such as metabolomics in Shc] ) to trigger the activation of signaling molecules such as Ras, Rho, phosphatidylinositol-3-kinase (PI3K), and mitogen-activated protein kinases (MAPKs), which then activate endothelial nitric oxide synthase (eNOS), Smad1/5, and the transcription factors and cofactors (eg, Kruppel-like factor 2 [KLF2], nuclear factor-κB [NF-κB], and activator protein 1 [AP-1]) to regulate the expression of several functional genes, such as eNOS, vascular cell adhesion protein 1 (VCAM-1), and monocyte chemoattractant protein-1 (MCP-1), as well as microRNAs (miRs). This diagram illustrates that multiple signaling pathways coordinate to form mechanoresponsive networks to modulate endothelial cell (EC) phenotype and function. AMPKs indicates AMP-activated protein kinases; BMPR, bone morphogenetic protein receptor; ERK, extracellular-signal-regulated kinase; FAK, focal adhesion kinase; HDAC, histone deacetylase; MEF2, myocyte enhancer factor-2; MPAKs, mitogen-activated protein kinases; mTOR, mammalian target of rapamycin; PYK2, prolinerich tyrosine kinase 2; SREBP2, sterol regulatory element binding protein 2; and VEGFR2, vascular endothelial growth factor receptor-2.
atherosusceptible endothelium, are restricted by the limited size of the specimen within the hemodynamic regions of interest and potential inclusion of multiple cell types. It would be of interest to overcome these technical hurdles to gain comprehensive insights for vascular disease progression.
Shear Stress Modulation of Communication Between ECs and Smooth Muscle Cells
In vivo investigations with animal models have shown an accelerated neointimal hyperplasia of the vessels after disturbance or cessation of blood flow in comparison with sham-operated controls with normal blood flow. 35, 81 In vitro experiments corroborate and greatly extend the in vivo findings by showing that application of atheroprotective shear stress to ECs cocultured with vascular SMCs causes phenotypic switch of SMCs from dedifferentiation to differentiation, induces contractile marker expression, and inhibits SMC migration and proliferation. [82] [83] [84] In contrast, application of atheroprone shear stress to ECs decreases SMC contractile marker genes (eg, smooth muscle α-actin and myocardin) and induces SMC proinflammatory phenotype (eg, expressions of VCAM-1, IL-8, and MCP-1). 85 Several secretory molecules that mediate the flow-regulated effects via ECs on SMC gene expression and phenotype have been documented, including NO, 83, 86 prostacyclin, 87 platelet-derived growth factor-BB and transforming growth factor-β1, 88 and miRs 81, 89 (Figure 2 ). MiR-143/ niR-145 secreted by LSS-stimulated ECs have been shown to target gene expression and control phenotypes in cocultured SMCs. 89 MiR-143/miR-145-containing extracellular vesicles derived from KLF2-expressing ECs can reduce atherosclerotic lesion formation in the aorta of ApoE −/− mice. 89 More recently, we also reported the findings of miRs in EC-SMC communication by showing that the endothelial miR-126/argonaute 2 complex targets gene expression in the cocultured SMCs to increase SMC turnover and that such effects are reduced by the application of atheroprotective LSS to ECs. 81 Systemic depletion of miR-126 in mice inhibited neointimal lesion formation of carotid arteries induced by cessation of blood flow. 81 These results suggest that the manipulation or interference of EC-secreted miRs provides a promising strategy to combat atherosclerosis.
Concluding Remarks and Perspectives
Hemodynamic forces can modulate the gene expression and phenotype of vascular ECs in vitro and in vivo. LSS and PSS that have well-defined directions are of utmost importance in maintaining vascular homeostasis. They activate signal transduction pathways and gene expression in ECs to suppress aberrant EC proliferation, inflammation, and atherosclerosis. In contrast, oscillating shear stress with a low mean value and a reciprocating flow promotes atheroprone phenotype of ECs, with increases in EC proliferation, inflammation, leukocyte 
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Arterioscler Thromb Vasc Biol October 2014 adhesion, lipoprotein uptake, and SMC migration and proliferation, thus contributing to atherogenesis. The diversity of endothelial functions is reflected in the variety of mechanisms of shear stress-induced signaling and suggests that multiple mechanisms are coordinated in response to a given type of stimulus. A major challenge in this field is the integration of a large body of data on EC responses to shear stress with different flow patterns at the molecular level and the global scale to identify the shear stress-specific endothelial gene expression and phenotype. System-targeted high-throughput sequencing with increasingly sophisticated statistical and bioinformatics analyses are of particular importance in determining the intercellular and intracellular flow-responsive networks. Comparisons of genomic, epigenomic, translational, and posttranslational profiles in the atherosusceptible and atheroresistant regions of arteries in vivo will enable the identification of genes and regulatory networks that may have direct pathophysiological relevance to endothelial function in health and disease. Current analyses have suggested that endothelial phenotypes are highly heterogeneous over different regions of the arterial trees. Analyses on homogenates of endothelium may mask and neutralize the changes in cells of interests because of the presence of cells with different behaviors in neighboring locations. Therefore, spatial and temporal studies on genomic and epigenomic profiling at single cell level would be a fruitful future direction. In addition, other biochemical risk factors (eg, cholesterol, glucose, as well as blood cells) may also play important roles in regulating EC function, in conjunction with hemodynamic regulators. The interplays between mechanical and biochemical factors in atherogenesis remain to be elucidated. Therapeutic application of the currently identified target biomarkers for atherogenesis should not only focus on signal molecules but also consider the possible involvement of multiple targets in a variety of fundamental cellular processes. An attractive therapeutical option is the combined targeting of multiple molecules in the same or opposite pathways to achieve synergistic effects.
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